Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date28 Aug 2020 |
A Retrospective, Real-world Study of Eucalyptol, Limonene and Pinene Enteric Soft Capsules Used in the Expectorant Treatment of Community-acquired Pneumonia
Through a series of retrospective analysis, it is hoped that an objective evaluation of the effect and safety of Eucalyptol, Limonene and Pinene Enteric Soft Capsules in the treatment of community-acquired pneumonia can be made.
100 Clinical Results associated with Beijing Grand Johamu Pharmaceutical Company, Ltd.
0 Patents (Medical) associated with Beijing Grand Johamu Pharmaceutical Company, Ltd.
100 Deals associated with Beijing Grand Johamu Pharmaceutical Company, Ltd.
100 Translational Medicine associated with Beijing Grand Johamu Pharmaceutical Company, Ltd.